Related Experiment Video

Updated: Oct 2, 2026

Production and Detection of Reactive Oxygen Species (ROS) in Cancers
07:17

Production and Detection of Reactive Oxygen Species (ROS) in Cancers

Published on: November 21, 2011

[Study on the relationship between apoptosis and reactive oxygen species of cancer cell lines induced by

L Cai1, S Gao, Y Yang

  • 1China-Japan Union Hospital of Norman Bethune Medical University, Changchun 130031, China.

Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|March 6, 2002
PubMed
Abstract

Insights

Anticancer agents stimulate reactive oxygen species (ROS) production, leading to apoptosis (AP) in K562 cancer cells. This study identifies optimal drug concentrations for inducing these effects, offering insights into drug sensitivity and resistance mechanisms.

Area of Science:

  • Cell biology
  • Biochemistry
  • Pharmacology

Context:

  • Cancer cell lines are crucial models for understanding drug efficacy.
  • Apoptosis (AP) and reactive oxygen species (ROS) are key factors in cancer therapy.
  • Drug sensitivity and resistance mechanisms remain incompletely understood.

Purpose:

  • To investigate the relationship between apoptosis (AP) and reactive oxygen species (ROS) in K562 cancer cells treated with anticancer agents.
  • To elucidate the role of ROS in mediating drug-induced apoptosis.
  • To determine optimal drug concentrations for inducing AP and ROS.

Summary:

  • K562 cells were treated with Vp16, ADR, and DDP, and ROS fluorescent intensity and AP percentage were measured using flow cytometry.
  • Anticancer agents significantly increased ROS production and AP in K562 cells compared to controls.
  • The study determined optimal drug concentrations for inducing ROS and AP, suggesting ROS stimulation as a potential mechanism for drug-induced apoptosis.

Impact:

  • Provides a mechanistic link between ROS production and apoptosis induction by anticancer drugs.
  • Offers insights into the cellular responses that govern sensitivity and resistance to chemotherapy.
  • Contributes to the development of more effective cancer treatment strategies.

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...